2. Một số mối liên quan của các typ mô họ cu tuyến thượng thận:
TIẾNG VIỆT
1. Lê Thị Vân Anh (2007): "Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị một số loại u tuyến thượng thận thường gặp", Luận văn tốt nghiệp bác sĩ nội trú bệnh viện, Trường ĐHYHN.
2. Phạm Minh Đức (2000): "Tuyến thượng thận", Sinh lý học, tập 2, NXBYH: 83-96.
3. Nguyễn Duy Huề, Nguyễn Đình Minh, Nguyễn Đức Tiến (2004): “Chụp cắt lớp vi tính trong chẩn đoán u tuyến thượng thận, nhân 102 bệnh nhân”, Y học thực hành công trình nghiên cứu khoa học hội nghị
ngoại khoa toàn quốc, tr: 590-594.
4. Đỗ Kính (2001): "Hệ nội tiết",Phôi thai học, NXBYH: 600-603.
5. Đỗ Kính (2003): "Tuyến thượng thận",Mô học, NXBYH: 627-633.
6. Nguyễn Đình Minh (2003): "Nghiên cứu giá trị của chụp cắt lớp vi tính trong chẩn đoán u tuyến thượng thận", Luận văn tốt nghiệp bác sĩ nội trú bệnh viện, Trường ĐHYHN.
7. Đỗ Trung Quân (1995): "Góp phần chẩn đoán và điều trị hội chứng Cushing", Luận văn phó tiến sĩ khoa học y dược, Trường ĐHYHN.
8. Đỗ Trung Quân, Hoàng Đức Kiệt (1996): “Giá trị của chụp cắt lớp vi
tính trong chẩn đoán bệnh lý tuyến thượng thận”, Tạp chí Y học Việt Nam; 208, 9:71-73.
9. Nguyễn Đức Tiến (2002): “Nghiên cứu ứng dụng mổ nội soi qua phúc mạc các u tuyến thượng thận tại bệnh viện Việt Đức”, Luận văn thạc sỹ
y học, trường ĐHYHN.
10.Nguyễn Đức Tiến (2006): “Nghiên cứu chẩn đoán và điều trị phẫu thuật nội soi các u tuyến thượng thận lành tính tại bệnh viện Việt Đức giai đoạn 1998-2005”, Luận án tiến sĩ y học, trường ĐHYHN.
11.Nguyễn Đức Tiến, Trần Bình Giang (2006): “Phẫu thuật nội soi u tuyến thượng thận”, Y học Việt Nam số đặc biệt chuyên đề phẫu thuật nội soi và nội soi can thiệp, tr: 326-331.
12.Mai Thế Trạch, Nguyễn Thy Khuê (2003): "Tuyến thượng thận", Nội tiết học đại cương, NXBYH: 211-270.
13.Nguyễn Bửu Triều, Lê Ngọc Từ, Hoàng Long (2001): “Kết quả điều trị cắt u tuyến thượng thận bằng phương pháp kiểm soát mạch máu trước”, Y học Việt Nam, tập 4, số 5, tr: 143-151.
15.Lewis Landsberg, James B. Young, Lê Thành Uyên (1999): "Sinh lý học và dược lý học của hệ thần kinh thực vật", Các nguyên lý y học nội khoa, tập 1, NXBYH: 643-663.
TIẾNG ANH
16. Ahmed F, Cardinez CJ, Jamison PM, et al. (2007). Cancer incidence in the USA, National Program of Cancer Registries (NPCR) 1998-2002. In: Curado MP, Edwards B, Shin HR, et al., eds., IARC Scientifc Publications, Number 160, Cancer incidence in five continents, Volume IX. Lyon, France: International Agency for Research on Cancer. Available from: http://www-dep.iarc.fr/ Date Accessed: November 12, 2008
17. Anna A. Kasperlik-Zalu ska, Barbara M. Migdalska, Stefan Zgliczy ski, Anna M. Makowska: (1995): Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer. May 15;75(10):2587-91.
18. Andjelković Z, Tavcar I (2002): Personal experience in diagnosis and localization of pheochromocytoma. Srp Arh Celok Lek;130 Suppl 2:14-9.
19. Aquirre P, Scully R E (1983): Testosterone-secreting adrenal ganglioneuroma containing Leydig cells.Am J Surg Pathol 7: 699-705.
20. Arnaldi G, Masini AM, Giacchetti G, Taccaliti A, Faloia E, Mantero F (2000): Adrenal incidentaloma. Braz J Med Biol Res 33: 1177-1189
21. Aubert S, Wacrenier A, Leroy X, Devos P, Carnaille B, Proye C, Wemeau JL, Lecomte-Houcke M, Leteurtre E (2002): Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 26: 1612-1619.
22. Beard CM, Sheps SG, Kurland LT, Carney JA, Lie JT (1983):
Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 58: 802-804
23. Bennett B, McKenna TJ, Hough AJ, et al (1980): Adrenal myelolipoma associated with Cushing’s disease. Am J Clin Pathol;73:443-447.
25. Boneschi M, Erba M, Beretta L, Miani S, Bortolani EM (1998):
Adrenal carcinoma. Clinical and anatomopathological prognostic factors. Minerva Chir; 53(3): 167-72.
26. Brown FM, Gaffey TA, Wold LE, Lloyd RV (2000): Myxoid neoplasms of the adrenal cortex: a rare histologic variant. Am J Surg Pathol. Mar;24(3):396-401.
27. Bulow B, Ahren B (2002): Adrenal incidentaloma - experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 252: 239-246.
28. Busam KJ, Iversen K, Coplan KA, Old LJ, Stockert E, Chen YT, McGregor D, Jungbluth A (1998): Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other seroid tumors. Am J Surg Pathol 22: 57-63
29. Cheng L, Ulbright TM (2004): Adenomatoid tumour. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization Classification of Tumours, Tumours of Endocrine Organs. IARC Press, Lyon, France, pp 167.
30. Cheng L, Ulbright TM (2004): Sex cord-stroma tumour. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization Classification of Tumours, Tumours of Endocrine Organs. IARC Press, Lyon, France, pp 168.
31. Clark OH, Duh QY, Perrier ND, Jahan TM(2003): Atlas of clinical oncology Endocrine Tumors. BC Decker Inc Hamilton, London, 93-147.
32. Conn J W, Knopf R F, Nesbit R M (1964): Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg 107: 159-172.
33. Corree P, Chen VW (1995): Endocrine gland cancer. Cancer 75: 338-352
34. Danilowicz K, Albiger N, Vanegas M, Gomez RM, Cross G, Bruno OD (2002): Androgen-secreting adrenal adnomas. Obstet Gynecol 100: 1099-1102.
35. De Graeff J, Horak BJV (1964): The incidence of phaeochromocytoma in the Netherlands. Acta Med Scand 176: 583-593. 36. Decker RA, Kuehner ME (1991): Adrenocortical carcinoma. Am
Endocrine Organs. IARC Press, Lyon, France, pp 135-173.
38. Delellis R A, Mangray S (2004): The adrenal glands. Sternberg's Diagnostic Surgical Pathology, 4th edition, Lippincott Williams & Wilkins: 621-667.
39. Didolkar MS, Bescher RA, Elias EG, Moore RH (1981): Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer; 47(9): 2153-61.
40. El-Mekresh MM, Abdel-Gawad M, El-Diasty T, El-Baz M, Ghoneim MA (1996): Clinical, radiological and histological features of adrenal myelolipoma: review and experience with a further eight cases.
British Journal of Urology, 78: 345-350.
41. Erlandson RA, Reuter VE (1991): Oncocytic adrenal cortical adenoma. Ultrastruct Pathol 15:539-547.
42. Favia G, Lumachi F, Gregianin M, Polistina F, Borsato S, D'Amico DF (1997): Adrenal incidentaloma: proposal for a correct treatment. Ann Ital Chir; 68(4): 517-22.
43. Favia G, Lumachi F, Basso S, D'Amico DF (2000): Management of incidentally discovered adrenal masses and risk of malignancy. Surgery; 128(6): 918-24.
44. Gabrilove J L. Sharma D C, Woftiz H H et al. (1965): Feminizing adrenocortical tumors in the male. A review of 52 cases including a case report. Medicine 44: 37-79.
45. Gaffey MJ, Traweek ST, Mills SE, Travis WD, Lack EE, Medeiros LJ, Weiss LM (1992): Cytokeratin expression in adrenocortical neoplasia: an immunohistochemical and bio chemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma. Hum Pathol 23: 144-153.
46. Hidai H, Fuji H, Otsuka K, er al (1975): Cushing’s syndrome due to huge adrenocortical multinodular hyperplasia. Endocrinol Jpn;22:555-560.
47. Hough AJ, Hollifield JW, Page DL, Hartmann WH (1979):
Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am J Clin Pathol 72: 390-399.
48. Janković R, Diklić A, Paunović I, Krgović K, Hivaljević V, Todorović-Kazić M, Havelka M, Tatić S, Dimitrijević N (2002):
49. Jeffrey A. Norton, Hop N. Le (2001): Adrenal tumors, Principles and Practice of Oncology, 6th Edition, chapter 38, Lippincott Williams & Wilkins.
50. John H, Ziegler WH, Hauri D, Jaeger P (1999):
Pheochromocytomas: can malignant potential be predicted? Urology 53: 679-683.
51. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. (1995): Incidentally discovered adrenal masses. Endocr Rev. 1995 Aug;16(4):460-84.
52. Kuhn JM, Lefebvre H, Duparc C, Pellerin A, Luton JP, Strauch G (2002): Cosecretion of estrogen and inhinbin B by a feminizing adrenocortical adenoma: impact on gonadotropin secretion. J Clin Endorinol Metab 87: 2367-2375
53. Lack E E (1990): In: Lack E E (ed) Pathology of the adrenal glands. Churchill Livingstone, New York, p 173-235.
54. Lack E E (1994): Pathology of adrenal and extra-adrenal paraganglia. Major problems in surgical pathology, vol 29. W B Saunders, Philadelphia.
55. Lack E E (1997): Tumors of the adrenal gland and extra-adrenal paraganglia. Atlas of tumor pathology, 3rd series, fascicle 19. Armed Forces Institute of Pathology, Washington, D C.
56. Lack E E (2007): Tumors of the adrenal gland. Diagnostic histopathology of tumors, 3rd edition. Churchill Livingstone: 1099- 1122.
57. Lack E E, Kozakewich H P W (1990): Adrenal neuroblastoma, ganglioneuroblastoma and related tumors. In: Lack E E (ed) Pathology of the adrenal glands. Churchill Livingstone, New York: 277-309.
58. Lam KY, Lo CY (1999): Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution. J Clin Pathol 54: 707-712.
59. Linos D, Heerden JA(2005): Adrenal Glands. Springer, 131-189. 60. Lloyd RV, Kawashima A, Tischler AS (2004): Adrenal soft tissue
and germ cell tumours. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization Classification of Tumours, Tumours of Endocrine Organs. IARC Press, Lyon, France, pp 169-171.
61. Lloyd RV, Tischler AS, Kimura N, McNicol AM, Young WF (2004): Adrenal tumors: Introduction, In: DeLellis RA, Lloyd RV, Heitz
62. Lumachi F, Borsato S, Tregnaghi A, Basso SM, Marchesi P, Ciarleglio F, Fassina A, Favia G (2003): CT-scan, MRI and image- guided FNA cytology of incidental adrenal masses. Eur J Surg Oncol;
29(8): 689-92.
63. Lumachi F, Borsato S, Tregnaghi A, Marino F, Fassina A, Zucchetta P, Marzola MC, Cecchin D, Bui F, Iacobone M, Favia G (2007): High risk of malignancy in patients with incidentally discovered adrenal masses: accuracy of adrenal imaging and image-guided fine- needle aspiration cytology. Tumori; 93(3): 269-74.
64. Mazzaglia PJ, Monchik JM (2009): Limited value of adrenal biopsy in the evaluation of adrenal neoplasm: a decade of experience.
Arch Surg; 144(5): 465-70.
65. McNicol AM, Young WF, Kawashima A, Komminoth P, Tischler AS (2004) Benign phaeochromocytoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization Classification of Tumours, Tumours of Endocrine Organs. IARC Press, Lyon, France, pp 151-155.
66. Medeiros LJ, Wolf BC, Balogh K, Federman M (1985): Adrenal pheochromocytoma: a clinicopathologic review of 60 cases. Hum Pathol
16: 580-589.
67. Melicow MM (1977): One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926-1976: a clinicopathological analysis. Cancer 40: 1987-2004.
68. Minutoli F, Pecorella GR, Cosentino S, Lipari R, Baldari S (2002): Scintigraphic features of a pure estrogen-secreting adrenocortical adenoma in a patient with gynecomastia. Clin Nucl Med
27: 741-742.
69. Modlin IM, Farndon JR, Shepherd A, Johnstion ID, Kennedy TL, Montgomery DA, Welbourn RB (1979): Phaeochromocytomas in 72 patients: clinical and diagnostic features, treatment and long term results. BR J Surg 66: 456-465.
70. Munro LM, Kennedy A, McNicol AM (1999): The expression of inhibin/activin subunits in the human adrenal cortex and its tumours. J
Endocrinol 161: 341-347.
71. Musante F, Derchi LE, Zappasodi F et al (1988): Myelolipoma of the adrenal gland: sonographic and CT features. AJR;151: 961-964. 72. Nader S, Hickey RC, Sellin RV, Samaan NA (1983): Adrenal
74. Neville AM, O’Hare MJ (1979): Aspects of structure, function and pathology. In: Jame VHT, ed. The adrenal gland. New York: Raven Press:165.
75. Neville AM (1978): The nodular adrenal. Invest Cell Pathol;1:99- 111.
76. Ornvold K, Ralfkiaer E, Carstensen H (1990):
Immunohistochemical study of abnormal cells in Langerhans cell histiocytosis (histiocytosis x). Virchows Arch A Pathol Anat Histopathol
416: 403-410.
77. Page DL, DeLellis RA, Hough AJ (1985): Tumors of the adrenal. In: Atlas of tumor pathology, 2ndseries, fascicle 23. Washington, DC: Armed Forces Institute of Pathology.
78. Plaut A (1962): Hemangiomas and related lesions of the adrenal gland. Virchows Arch [A] 335: 345-355.
79. Pollock W J, McConnell C F, Hilton C et al, (1986): Virilizing Leydig cell adenoma of adrenal gland. Am J Surg Pathol 10: 816-822.
80. Puchner MJ, Ludecke DK, Saeger W, Riedel M, Asa SL (1995): Gangliocytomas of the sellar region - a review. Exp Clin Endocrinol Diabetes 103: 129-149.
81. Rosai J (1996): Adrenal gland and other paraganglia. In: Rosai J, ed. Ac kerman’s Surgical Pathology. 8th ed. St Louis: Mosby – Year Book:
1015-1058.
82. Saeger W. (1995): Pathology of adrenal neoplasms. Minerva Endocrinol. Mar;20(1):1-8.
83. Saladin K S (2004): The endocrine system, Anatomy and Physiology, 3rd edition, chapter 17, McGraw-Hill: 648-649.
84. Sasano H, Shizawa S, Suzuki T, Takayama K, Fukaya T, Morohashi K, Nagura H (1995): Ad4BP in the human adrenal cortex and its disorders. J Clin Endocrinol Metab 80: 2378-2380.
85. Sasano H, Szuki T, Sano T, et al (1995): Transcription factor adrenal 4 binding protein is a marker of adrenocortical malignancy.
Hum Pathol 26:1154-1156.
86. Sasano H, Young WF, Chrousos GP, Koch CA, Giordano TJ, Kawashima A (2004): Adrenal cortical adenoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization
87. Scopsi L, Castellani MR, Gullo M, Cusumano F, Camerini E, Pasini B, Orefice S (1996): Malignant pheochromocytoma in multiple endocrine neoplasia type 2B syndrome. Case report and review of the literalture. Tumori 82:480-484.
88. Scott HWJr, Halter SA (1984): Oncologic aspects of pheochromocytoma: the importance pf follow-up. Surgery 96; 1061- 1066.
89. Scott HWJr, Reynolds V, Green N, Page D, Oates JA, Robertson D, Roberts S (1982): Clinical experience with malignant pheochromocytomas. Surg Gynecol Obstet 154: 801-818.
90. Shumam WP, Moss AA (1992): The adrenal glands. In: Mpss AA. Gamsu G, Genant HK, eds. Computed Tomography of the Body with Magnetic Resonance Imaging. Philadelphia: WB SUNSWEA Co: 1021- 1057.
91. Stewart PM (2002): The adrenal cortex. In: Williams Textbook of Endocrinology, Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds., 10th ed. Saunders: Philadelphia, pp. 491-551.
92. Sullivan M, Boileau M, Hodges CV. (1978): Adrenal cortical carcinoma. J Urol. Dec;120(6):660-5.
93. Symington T (1982): The adrenal cortex. In: Bloodworth JMB Jr., ed. Endocrine pathology general and surgical. Baltimore: William & Wilkins:419-472.
94. Thompson LD (2002): Pheochromcytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26:551-566.
95. Thompson LDR, Young WF, Kawashima A, Komminoth P, Tischler AS (2004): Malignant adrenal phaeochromocytoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization Classification of Tumours, Tumours of Endocrine Organs. IARC Press, Lyon, France, pp 147-150.
96. Tischler AS, Kimura N, Lloyd RV, Komminoth P (2004)
Composite phaeochromocytoma or paraganglioma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization Classification of Tumours, Tumours of Endocrine Organs. IARC Press, Lyon, France, pp 156-158.
97. Travis W D, Lack E E, Azumi N et al. (1990): Adenomatoid tumor of the adrenal gland with ultrastructure and immunohistochemical
98. Van Slooten H. Schaberg A, Smeenk D, Moolenaar AJ (1985):
Morphologic characteristics of benign and malignant adrenocortical tumor. Cancer 55: 766-773.
99. Vilar L, Freitas Mda C, Canadas V, Albuquerque JL, Botelho CA, Egito CS, Arruda MJ, Moura e Silva L, Coelho CE, Casulari LA, Naves LA. (2008): Adrenal incidentalomas: diagnostic evaluation and long-term follow-up. Endocr Pract. 2008 Apr;14(3):269-78.
100. Walther MM, Keiser HR, Choyke PL, Rayford W, Lyne JC, Linehan WM (1999): Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy. J Urol161:
395-398.
101. Weiss LM, Bertagna X, Chrousos GP, Kawashima A, Kleihues P, Koch CA, Giordano TJ, Merino LJ, Ordonez NG, Sasano H (2004):
Adrenal cortical carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization Classification of Tumours, Tumours of Endocrine Organs. IARC Press, Lyon, France, pp 139-142.
102. Weiss LM, Medeiros LJ, Vickery ALJr (1989): Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13: 202-206.
103. Wenig BM, Heffess CS, Adair CF (1997): Atlas of endocrine pathology. Philadelphia: wb Saunders.
104. Young WFJr (2000): Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29: 159-185